🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism

RecruitingNAAges 18 Years - anyAllAarhus University Hospital
NCT06222606 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age\>18 years and able to give informed consent. * Suspicion or diagnosis of thyroid cancer. * Planned total thyroidectomy or completion thyroidectomy. * Normocalcemia prior to surgery. Exclusion Criteria: * Planned simultaneous parathyroid surgery. * Treatment with active vitamin D analogues. * eGFR \< 30.
💊

What it tests

  • Surgery with autofluorescence
📍

Where

1 site
Aarhus University Hospital
Aarhus, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy